Bioventus's total assets for Q3 2024 were $769.49M, a decrease of -2.86% from the previous quarter. BVS total liabilities were $582.66M for the fiscal quarter, a -3.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.